PharmaResearch
Financials
Valuation Metrics
PharmaResearch's Market Cap is ₩2.3T. At end of 2025 it was ₩4.2T. Ranked #167 of 2,405 in KR market (top 7%), #22 of 1,627 on KOSDAQ (top 1%), #10 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 4%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 2.32T KRW | KR#167/2,405 Sec#10/231 |
| Revenue | 603.58B KRW | KR#555/2,405 Sec#25/231 |
| Net Income | 195.16B KRW | KR#153/2,405 Sec#8/231 |
| Total Assets | 1.11T KRW | KR#454/2,405 Sec#25/231 |
| Net Assets | 788.87B KRW | KR#352/2,405 Sec#23/231 |
| Employees | 436 | KR#563/2,405 Sec#45/231 |
| Value | ||
| P/E | 11.87x | KR#969/2,405 Sec#53/231 |
| P/B | 2.94x | KR#2,131/2,405 Sec#171/231 |
| PEG | 0.19x | KR#573/2,405 Sec#33/231 |
| P/S | 3.84x | KR#2,087/2,405 Sec#132/231 |
| EV/EBITDA | 8.85x | KR#580/2,405 Sec#26/231 |
| FCF Yield | 6.62% | KR#793/2,405 Sec#38/231 |
| Profitability | ||
| ROE | 24.74% | KR#105/2,405 Sec#8/231 |
| ROA | 17.63% | KR#74/2,405 Sec#6/231 |
| Op. Margin | 39.36% | KR#27/2,405 Sec#6/231 |
| Revenue Growth | 34.19% | KR#335/2,405 Sec#34/231 |
| Earnings Growth | 61.22% | KR#513/2,405 Sec#34/231 |
| Financial Health | ||
| Debt Ratio | 40.35% | KR#793/2,405 Sec#93/231 |
| Total Debt | 6.51B KRW | KR#1,731/2,405 Sec#163/231 |
| FCF | 153.44B KRW | KR#136/2,405 Sec#5/231 |
| Cash | 220.29B KRW | KR#243/2,405 Sec#8/231 |
| Current Ratio | 7.72x | KR#151/2,405 Sec#33/231 |
| Net Debt/EBITDA | -0.90x | KR#404/2,405 Sec#22/231 |
| Dividend | ||
| Div. Yield | 1.66% | KR#995/2,405 Sec#53/231 |
| Div. Growth | 236.36% | KR#40/2,405 Sec#1/231 |
| Performance | ||
| 1Y Return | -58.78% | KR#2,143/2,405 Sec#198/231 |
| 1M Return | -27.12% | KR#2,151/2,405 Sec#212/231 |
| From 52W High | -60.46% | KR#1,686/2,405 Sec#140/231 |
| 1Y MDD | -61.31% | KR#1,525/2,405 Sec#123/231 |
| Trading | ||
| Volume | 64,979 shares | KR#825/2,405 Sec#90/231 |
| Trading Value | 14.36B KRW | KR#153/2,405 Sec#9/231 |
| Foreign Own. | 11.09% | KR#438/2,405 Sec#34/231 |
| Per Share | ||
| EPS | 18,784 KRW | KR#55/2,405 Sec#2/231 |
| BPS | 75,929 KRW | KR#180/2,405 Sec#10/231 |
Company Info
PharmaResearch was founded in 2001 as a pharmaceutical and medical device development and consulting company, later establishing a GMP-certified factory in 2013 and completing its second factory in 2019. As a biopharmaceutical company, it researches, manufactures, and sells pharmaceuticals, medical devices, and cosmetics for various medical fields, including dermatology and orthopedics. Leveraging its technological competitiveness, the company is committed to R&D and market expansion, pursuing global business by entering Asian, European, and North American markets. PharmaResearch was established in 2001 and is headquartered in Gangneung-si, Gangwon-do.